GATA3 |
CD4+ T-cells |
Th1 |
Permissive
|
Mus musculus |
GSE28292
...
|
MA0037.3
|
GATA3 |
CD4+ T-cells |
Th2 |
Permissive
Robust
|
Mus musculus |
GSE28292
...
|
MA0037.3
|
GATA3 |
CD4+ T-cells |
TGF-β +IL-4 |
Permissive
Robust
|
Mus musculus |
GSE72051
...
|
MA0037.3
|
GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
ICI |
Permissive
Robust
|
Homo sapiens |
GSE81510
...
|
MA0037.3
|
GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE81510
...
|
MA0037.3
|
GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
E2, DEX |
Permissive
Robust
|
Homo sapiens |
GSE81510
...
|
MA0037.3
|
GATA3 |
CLB-Ga (neuroblastoma) |
none |
Permissive
Robust
|
Homo sapiens |
GSE90683
...
|
MA0037.3
|
GATA3 |
breast tumor |
Male |
Permissive
|
Homo sapiens |
GSE104399
...
|
MA0037.3
|
GATA3 |
WA09 (embryonic stem cells) |
BMP4 for 3 day |
Permissive
Robust
|
Homo sapiens |
GSE105081
...
|
MA0037.3
|
GATA3 |
WA09 (embryonic stem cells) |
BMP4 for 3 day |
Permissive
Robust
|
Homo sapiens |
GSE105081
...
|
MA0037.3
|
GATA3 |
WA09 (embryonic stem cells) |
BMP4 for 3 day |
Permissive
Robust
|
Homo sapiens |
GSE105081
...
|
MA0037.3
|
GATA3 |
A1-2 (breast cancer cells) |
1hr EtOH |
Permissive
|
Homo sapiens |
GSE112491
...
|
MA0037.3
|
GATA3 |
A1-2 (breast cancer cells) |
Treatment: 1hr Dex |
Permissive
|
Homo sapiens |
GSE112491
...
|
MA0037.3
|
GATA3 |
A1A3(breast cancer cells) |
Treatment: 1hr EtOH, PBS 72 hr CellLine: A1A3 from T47D cell line |
Permissive
Robust
|
Homo sapiens |
GSE112491
...
|
MA0037.3
|
GATA3 |
A1A3(breast cancer cells) |
Treatment: 1hr Dex, PBS 72 hr CellLine: A1A3 from T47D cell line |
Permissive
|
Homo sapiens |
GSE112491
...
|
MA0037.3
|
GATA3 |
A1A3(breast cancer cells) |
Treatment: 1hr EtOH, Doxycycline 72 hr CellLine: A1A3 from T47D cell line Genotype: Brg1 knockdown |
Permissive
Robust
|
Homo sapiens |
GSE112491
...
|
MA0037.3
|
GATA3 |
A1A3(breast cancer cells) |
Treatment: 1hr Dex, Doxycycline 72 hr CellLine: A1A3 from T47D cell line Genotype: Brg1 knockdown |
Permissive
|
Homo sapiens |
GSE112491
...
|
MA0037.3
|
GATA3 |
Kelly (neuroblastoma) |
Treatment: untreated |
Permissive
|
Homo sapiens |
GSE94822
...
|
MA0037.3
|
GATA3 |
BE2C |
Treatment: untreated |
Permissive
Robust
|
Homo sapiens |
GSE94822
...
|
MA0037.3
|
GATA3 |
T47D (invasive ductal carcinoma) |
Passsage: <10 |
Permissive
Robust
|
Homo sapiens |
GSE99479
...
|
MA0037.3
|
GATA3 |
T47D (invasive ductal carcinoma) |
Passsage: <10 |
Permissive
Robust
|
Homo sapiens |
GSE99479
...
|
MA0037.3
|
GATA3 |
T47D (invasive ductal carcinoma) |
Passsage: <10 Genotype: wt/R330fs mutant with CRISPR |
Permissive
Robust
|
Homo sapiens |
GSE99479
...
|
MA0037.3
|
GATA3 |
T47D (invasive ductal carcinoma) |
Passsage: <10 Genotype: wt/R330fs mutant with CRISPR |
Permissive
Robust
|
Homo sapiens |
GSE99479
...
|
MA0037.3
|
GATA3 |
T47D (invasive ductal carcinoma) |
Passsage: <10 |
Permissive
Robust
|
Homo sapiens |
GSE99479
...
|
MA0037.3
|
GATA3 |
T47D (invasive ductal carcinoma) |
Passsage: <10 |
Permissive
Robust
|
Homo sapiens |
GSE99479
...
|
MA0037.3
|
GATA3 |
T47D (invasive ductal carcinoma) |
Passsage: <10 Genotype: wt/R330fs mutant with CRISPR |
Permissive
Robust
|
Homo sapiens |
GSE99479
...
|
MA0037.3
|
GATA3 |
T47D (invasive ductal carcinoma) |
Passsage: <10 Genotype: wt/R330fs mutant with CRISPR |
Permissive
Robust
|
Homo sapiens |
GSE99479
...
|
MA0037.3
|
GATA3 |
Th2-cells |
Source: late Th2 Genotype: wildtype |
Permissive
Robust
|
Mus musculus |
GSE109107
...
|
MA0037.3
|
GATA3 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with pMxs-Mock-hNGFR Strain: CB17-Prkdc<scid> mice |
Permissive
|
Mus musculus |
GSE93755
...
|
MA0037.3
|
GATA3 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with pMxs-Mock-hNGFR Strain: CB17-Prkdc<scid> mice |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0037.3
|
GATA3 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with pMxs-PU.1-hNGFR Strain: CB17-Prkdc<scid> mice |
Permissive
|
Mus musculus |
GSE93755
...
|
MA0037.3
|
GATA3 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with pMxs-PU.1-hNGFR Strain: CB17-Prkdc<scid> mice |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0037.3
|
GATA3 |
ILC2 (type 2 Innate lympoid cells) |
Growth: with IL-2/IL-7/IL-33 for 4 weeks, and withour IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung |
Permissive
Robust
|
Mus musculus |
GSE111871
...
|
MA0037.3
|
GATA3 |
ILC2 (type 2 Innate lympoid cells) |
Growth: with IL-2/IL-7/IL-33 for 4 weeks, and with IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung |
Permissive
Robust
|
Mus musculus |
GSE111871
...
|
MA0037.3
|
GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: with Estrogen; |
Permissive
Robust
|
Homo sapiens |
GSE117492
...
|
MA0037.3
|
GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: with Estrogen +1,6-Hexanediol; |
Permissive
|
Homo sapiens |
GSE117492
...
|
MA0037.3
|
GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BST
|
MA0037.3
|
GATA3 |
SK-N-SH (neuroblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BTH
|
MA0037.3
|
GATA3 |
A549 (lung carcinoma) |
|
Permissive
|
Homo sapiens |
ENCSR000BTI
|
MA0037.3
|
GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000EWS
|
MA0037.3
|
GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000EWV
|
MA0037.3
|
GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR423RTK
|
MA0037.3
|
GATA3 |
CD4- CD8- thymocytes |
|
Permissive
Robust
|
Mus musculus |
GSE20898
...
|
MA0037.3
|
GATA3 |
CD4+ T-cells |
|
Permissive
Robust
|
Mus musculus |
GSE20898
...
|
MA0037.3
|
GATA3 |
CD8+ T-cells |
|
Permissive
Robust
|
Mus musculus |
GSE20898
...
|
MA0037.3
|
GATA3 |
Th1-cells |
|
Permissive
Robust
|
Mus musculus |
GSE20898
...
|
MA0037.3
|
GATA3 |
Th17-cells |
|
Permissive
Robust
|
Mus musculus |
GSE20898
...
|
MA0037.3
|
GATA3 |
T-cells |
|
Permissive
Robust
|
Mus musculus |
GSE20898
...
|
MA0037.3
|
GATA3 |
T-cells |
|
Permissive
Robust
|
Mus musculus |
GSE20898
...
|
MA0037.3
|
GATA3 |
natural killer T cells |
|
Permissive
Robust
|
Mus musculus |
GSE20898
...
|
MA0037.3
|
GATA3 |
CD8+ T-cells |
|
Permissive
|
Mus musculus |
GSE20898
...
|
MA0037.3
|
GATA3 |
CD4+ CD8+ thymocytes |
|
Permissive
Robust
|
Mus musculus |
GSE20898
...
|
MA0037.3
|
GATA3 |
Th2-cells |
|
Permissive
Robust
|
Mus musculus |
GSE20898
...
|
MA0037.3
|
GATA3 |
fetal liver precursors |
|
Permissive
Robust
|
Mus musculus |
GSE31233
...
|
MA0037.3
|
GATA3 |
fetal liver precursors |
|
Permissive
Robust
|
Mus musculus |
GSE31233
...
|
MA0037.3
|
GATA3 |
T-cells |
|
Permissive
Robust
|
Mus musculus |
GSE31233
...
|
MA0037.3
|
GATA3 |
Th1-cells |
|
Permissive
Robust
|
Homo sapiens |
GSE31320
...
|
MA0037.3
|
GATA3 |
Th2-cells |
|
Permissive
Robust
|
Homo sapiens |
GSE31320
...
|
MA0037.3
|
GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
|
Homo sapiens |
GSE67206
...
|
MA0037.3
|
GATA3 |
ILC3 (type 3 Innate lympoid cells) |
|
Permissive
Robust
|
Mus musculus |
GSE71198
...
|
MA0037.3
|
GATA3 |
ILC2 (type 2 Innate lympoid cells) |
|
Permissive
Robust
|
Mus musculus |
GSE71198
...
|
MA0037.3
|
GATA3 |
Th2-cells |
|
Permissive
Robust
|
Mus musculus |
GSE71198
...
|
MA0037.3
|
GATA3 |
CD4+ T-cells |
|
Permissive
Robust
|
Mus musculus |
GSE72051
...
|
MA0037.3
|
GATA3 |
MDA-MB-231 (breast adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE72141
...
|
MA0037.3
|
GATA3 |
MDA-MB-231 (breast adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE72141
...
|
MA0037.3
|
GATA3 |
MDA-MB-231 (breast adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE72141
...
|
MA0037.3
|
GATA3 |
trophoblast stem cells |
|
Permissive
|
Mus musculus |
GSE92287
...
|
MA0037.3
|
GATA3 |
Jurkat (T-cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE120063
...
|
MA0037.3
|
GATA3 |
Jurkat (T-cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE29180
|
MA0037.3
|
GATA3 |
CCRF-CEM (T acute lymphoblastic leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE33850
|
MA0037.3
|
GATA3 |
RPMI-8402 (T acute lymphoblastic leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE39179
|
MA0037.3
|
GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE51274
|
MA0037.3
|
GATA3 |
T47D (invasive ductal carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE51274
|
MA0037.3
|
GATA3 |
BE2C |
|
Permissive
Robust
|
Homo sapiens |
GSE65664
|
MA0037.3
|
GATA3 |
Kelly (neuroblastoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE65664
|
MA0037.3
|
GATA3 |
NGP (neuroblastoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE65664
|
MA0037.3
|
GATA3 |
SH-SY5Y (neuroblastoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE65664
|
MA0037.3
|
GATA3 |
Jurkat (T-cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE68976
|
MA0037.3
|
GATA3 |
thymocytes |
|
Permissive
Robust
|
Homo sapiens |
GSE71751
|
MA0037.3
|
GATA3 |
Jurkat (T-cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE76181
|
MA0037.3
|
GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
DMSO |
Permissive
Robust
|
Homo sapiens |
GSE29073
|
MA0037.3
|
GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE29073
|
MA0037.3
|
GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE40129
|
MA0037.3
|
GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
E2 |
Permissive
Robust
|
Homo sapiens |
GSE60270
|
MA0037.3
|
GATA3 |
|
TH1 |
Permissive
Robust
|
Homo sapiens |
GSE72266
|
MA0037.3
|
GATA3 |
|
TH2 |
Permissive
Robust
|
Homo sapiens |
GSE72266
|
MA0037.3
|
GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE40129
|
MA0037.3
|
GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE60270
|
MA0037.3
|